SMMT

Summit Therapeutics Inc.

Catalyst AI-extracted

ivonescimab

epidermal growth factor receptor-mutated locally advanced or metastatic non-squamous non-small cell lung cancer

221d ago Jan 12, 2026

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

Phase 2 Confirmed

ivonescimab

first-line metastatic NSCLC, squamous tumors

83d ago May 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

Phase 1 Confirmed

ivonescimab

non-small cell lung cancer (NSCLC)

82d ago May 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

PDUFA Confirmed

ivonescimab

EGFR-mutated locally advanced or metastatic non-squamous NSCLC post‑TKI therapy

T-minus 85 days Nov 14, 2026

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

Phase 3 Confirmed

ivonescimab

NSCLC

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

AdCom AI-extracted

ivonescimab

non-small cell lung cancer (NSCLC)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

Approval AI-extracted

ivonescimab

non-small cell lung cancer (NSCLC)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →

SMMT

Summit Therapeutics Inc.

CRL AI-extracted

ivonescimab

non-small cell lung cancer (NSCLC)

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →